Genetic and phenotypic attributes of splenic marginal zone lymphomaFerdinando Bonfiglio, Estella Matutes, L. Bonomini et al.|Blood|2021Cited by 96
Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burdenRahel Schwotzer, B. Gerber, Markus G. Manz et al.|Hematological Oncology|2019Cited by 34
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry studyB. Gerber, Guido Ghilardi, Thomas Pabst et al.|Bone Marrow Transplantation|2018Cited by 20
Venetoclax plus daratumumab induce hematological CR and organ response in an AL amyloidosis patient with t(11;14)Guido Ghilardi, B. Gerber, Georg Stüssi et al.|Amyloid|2019Cited by 19